Core Viewpoint - PureTech Health employs a hub-and-spoke model for drug development, focusing on a diversified and derisked approach to create innovative therapeutic treatments for patients [3]. Company Overview - Robert Lyne, the CEO of PureTech Health, has been in the role for two years and has a background in senior leadership positions within London-listed life science companies [2]. - The company aims to differentiate itself from other drug development businesses through its centralized, efficient hub that identifies novel opportunities for developing significantly different treatments [3].